Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: No elaboration on Germany in the Shareholder Letter
Reply New Message
Back To Forum List View

No elaboration on Germany in the Shareholder Letter

posted on Feb 09, 2009 11:35AM

I've got to think that RG purposely did not elaborate on Germany. I wish I knew the reasoning. I would guess that the "majority" of his recent shareholder questions were related to the German ruling.

Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply